Investors are frustrated with Botox-maker Allergan — and its CEO says it's 'deep into the process' of figuring out what to do next (AGN)

Reuters

• Allergan said Monday during its first-quarter earnings call that it's "deep into the process" of its strategic review of the company amid its stock price slipping over the past year. 
• Allergan CEO Brent Saunders outlined five possible approaches the company's exploring, which include divesting certain businesses. 
• Investors, Saunders said, are frustrated, and some of Allergan's top shareholders have approached activist investors to get involved in pushing for change at the company, Business Insider reported on Thursday. 

---

Allergan knows its investors are frustrated. 

Botox-maker Allergan reported its first-quarter earnings on Monday, announcing a better-than-expected profit and raising its forecast for the year. Still, the company's stock fell by 3% Monday morning. 

See the rest of the story at Business Insider

NOW WATCH: A $700 billion investor explains why traders should brush off an ominous market signal that's flashing

See Also:

• GM beats on earnings for 1st quarter
• Ford beats on first-quarter earnings — but kills sedans in USA
• Harley-Davidson beats on earnings and shares are rising in pre-market trading

SEE ALSO: Pharma dealmaking is starting to heat up — here's who likely to get acquired

DON'T MISS: Investors are angry with Botox-maker Allergan — and they're trying to get an activist involved to shake it up

from Feedburner https://ift.tt/2r9k1bJ